American Marconi Wireless News

NYSE - LSE

RBGPF	-5.79%	71.84	$
RIO	1.76%	61.86	$
NGG	-1.51%	71.01	$
GSK	0.58%	37.8	$
RELX	-2.2%	48	$
CMSC	0.39%	23.05	$
SCU	0%	12.72	$
CMSD	0.25%	23.58	$
BTI	0.96%	57.24	$
SCS	-0.76%	15.88	$
RYCEF	-0.7%	14.35	$
BCC	-1.34%	82.09	$
JRI	0.19%	13.435	$
BP	-0.15%	34.14	$
AZN	-0.69%	73.55	$
VOD	0.88%	11.36	$
BCE	2.34%	24.35	$

Featured

US astronaut Jim Lovell, commander of Apollo 13, dead at 97

US astronaut Jim Lovell, the commander of the Apollo 13 Moon mission which nearly ended in disaster in 1970 after a mid-flight explosion, has died at the age of 97, NASA announced Friday.

Fire extinguished, historic mosque-cathedral in southern Spain 'saved'

A fire broke out in the historic mosque-turned-cathedral in Cordoba on Friday but the monument was saved as firefighters quickly contained and then extinguished it, the Spanish city's mayor said.

Last news

MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain

Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion as the Company prepares to launch U.S. Phase 2a by year-end

CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase

U.S. CBD market projected to exceed $36 billion by 2032 as foot traffic rebounds in top-tier malls with over 122 million monthly U.S. shoppers - CBDL strategically positioned at the intersection of both trends

Blankit Media Aims to Build Thousands of AI Influencers with AI-Powered Tools

Revolutionizing the Creator Economy with Scalable, Fully AI-Generated Content

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy DesignationPotential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic hepatitisProposed acquisition strengthens Bausch Health's commitment to hepatology and patients suffering with liver disease complications globally

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025

RANCHO CUCAMONGA, CA / ACCESS Newswire / July 29, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2025 ended June 30, 2025, after the market closes on Thursday, August 7, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

Is DEA Marijuana Lies Civil Misconduct or Criminal Fraud? DEA Administrator's First Marijuana Decision

DEA Counsel's Conduct: Is It Fraud on the Tribunal?DEA attorney Aarathi D. Haig submitted a formal legal response on July 25, 2025 to DEA Administrator Terry Cole, asserting that MMJ BioPharma Cultivation lacked a bona fide supply agreement (BFSA) - the critical requirement for Schedule I bulk manufacturing registration.But this is provably false. That misrepresentation - made knowingly and in writing to the DEA Administrator and under the guise of the law - raises serious civil and criminal red flags.

Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.Hemogenyx Secures £250,000 to continue its Phase 1 Clinical Trials And Director's Dealing

Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze

NeuroX recently acquired the assets and operations of MindMaze, a world-renowned leader in evidence-based neurotherapeutic solutions for neurological diseases and brain disordersBusiness combination to create an expanded, SIX-listed, commercial-stage, AI-driven, scalable health tech companyBinding term sheet signed; transaction subject to customary conditions and approvalsClosing expected in Q4 2025

Trump warns of 'real starvation' in Gaza as aid deliveries pick up

US President Donald Trump warned Monday that the people of Gaza are facing "real starvation", as aid agencies sought to take advantage of an Israeli "tactical pause" in fighting to rush in food aid.

Heineken shares plummet as beer sales dry up

Shares in Dutch brewer Heineken plunged Monday after it reported a drop in beer sales in the first half of the year, with volumes down in the United States and Europe.

Landslide kills four as rains lash northern China

Torrential rain soaking northern China triggered a deadly landslide, burst riverbanks and washed away cars on Monday, with thousands of people forced to evacuate the days-long deluge.

Major Israeli rights groups brand Gaza campaign 'genocide'

Rights groups B'Tselem and Physicians for Human Rights Israel said on Monday that they had concluded the war in Gaza amounts to a "genocide" against Palestinians, a first for Israeli NGOs.

Hunger must never be 'weapon of war': UN chief

UN chief Antonio Guterres on Monday said food must not be used as a weapon of war as world leaders gathered for a food summit in Africa, where 280 million people face hunger and starvation.

France petition against bee-killing pesticide tops two million backers

A student-led petition against a chemical deadly to bees reached more than two million signatures in France on Monday, increasing pressure on the president not to sign a bill allowing its use into law.

Iconic French chef stakes reputation on vegan menu

Celebrated French chef Alain Passard has made history once again.

Four killed in landslide as heavy rain drenches northern China

Torrential rain soaking northern China triggered a deadly landslide, burst riverbanks and washed away cars on Monday, with thousands of people forced to evacuate the days-long deluge.

Head of China's Shaolin Temple removed over embezzlement claims

The head of the Chinese temple known as the birthplace of kung fu will be disrobed for "extremely" bad behaviour, Beijing's top Buddhist authority said Monday, after allegations of embezzlement saw him placed under investigation.

China's birthplace of kung fu rocked by embezzlement probe

Chinese authorities are investigating the head of the temple where kung fu was born over alleged embezzlement and other misconduct, the monastery said.

National Law Review and INSIDE Public Accounting Launch a New Monthly Newsletter

NLR x IPA Accounting News launched on July 23, bringing key accounting industry insights to its readers

Organto Foods Announces Appointment of Javier Reyes de la Campa as Co-Chair of the Board

VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / July 28, 2025 / Organto Foods Incorporated (TSX-V:OGO)(OTC:OGOFF) ("Organto" or the "Company") ("Organto" or the "Company") is pleased to announce the appointment of Mr. Javier Reyes de la Campa as Co-Chair of the Board of Directors, alongside Steve Bromley, effective immediately.

How Uniform Suppliers Help Ensure Safety Compliance in High-Risk Industries

NEW YORK CITY, NY / ACCESS Newswire / July 28, 2025 / Employees working in certain industries, like manufacturing, construction, or oil and gas, can face serious safety risks daily. In many of these environments, the uniform an employee wears isn't just a dress code; it often acts as their first line of defense against workplace injuries. That's why many business owners searching for "uniforms near me" are looking for a partner who understands the regulations and safety risks specific to their industry.

ISSA Show North America Launches Inaugural Global Collegiate Sales Competition

40 sales students will compete in live selling scenarios and connect with employers, bringing new talent into the growing cleaning sector.

MEDevice Silicon Valley 2025 Engineers Connections Through Multidimensional Approach

SANTA CLARA, CA / ACCESS Newswire / July 28, 2025 / MEDevice Silicon Valley, the premier West Coast event connecting medical device engineers and cutting-edge MedTech companies, is set to deliver its most dynamic and transformative event yet. Positioned at the heart of California's $32.6 billion MedTech economy and 83,000-strong industry workforce, MEDevice Silicon Valley has evolved into an electrifying catalyst for breakthrough collaborations.

110 Grill Announces New Athlete Partnership with Providence College Friar Ryan Mela

Local Basketball Standout and Sophomore Friar Joins Brand's Continued Support of College Athletics

Brenmiller Energy Signs Private Placement Agreement for up to $25 Million Equity Financing

Alpha Capital Anstalt, Brenmiller Energy's largest shareholder and long-standing investor, reinforces its strong commitment to the Company's long-term strategyThe Company will receive $1.2 million in an initial closing and an additional $3.8 million subject to certain conditionsAlpha Capital Anstalt has Additional Investment Rights for up to $20 million

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

DehydraTECH-semaglutide reduces overall side effects by 36.5% as compared to Rybelsus®DehydraTECH-semaglutide reduces gastrointestinal side effects by 43.5% as compared to Rybelsus®DehydraTECH-GLP-1 study arms evidencing patient safety and tolerability consistent with the primary study endpoint

MDCE (OTC PINK:MDCE) Partners with Influencer-Athlete Dominic Barry (1.1M Followers Combined) Ahead of DAZN Fight

MESA, ARIZONA / ACCESS Newswire / July 28, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is proud to announce that its premier sports memorabilia subsidiary, Infinite Auctions, is now an official sponsor of undefeated professional boxer, viral coach, and former NFL athlete Dominic Barry.

Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand

LAVAL, QC / ACCESS Newswire / July 28, 2025 / Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company") today announced that its subsidiary, Bausch Health Americas, Inc., has issued an irrevocable notice of redemption pursuant to which it will redeem approximately $602 million of aggregate principal amount of its outstanding 9.25% Senior Notes due 2026, CUSIP Nos. 91911XAV6 and U9098VAN2 (the "Notes"), using cash on hand. The redemption date is August 28, 2025. The notice of redemption has been issued to the record holders of such Notes. Nothing contained herein shall constitute a notice of redemption of the Notes. Payment of the redemption price and surrender of the Notes for redemption will be made through the facilities of the Depository Trust Company in accordance with the applicable procedures of the Depository Trust Company. The name and address of the U.S. paying agent are as follows: The Bank of New York Mellon, 240 Greenwich Street, Floor 7E, New York, New York 10286; Attn: Corporate Trust Administration. In connection with the redemption, the indenture pursuant to which the Notes were issued will be terminated.

Hypha Labs Provides Shareholder Update

LAS VEGAS, NEVADA / ACCESS Newswire / July 28, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), an Artificial Intelligence (AI) powered pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to provide a shareholder update from its Chief Executive Officer, Stone Douglass.

Dolphin Subsidiary 42West Dominates at San Diego Comic-Con (SDCC) 2025

Agency Highlights SDCC's Ongoing Role as a Global Hub for Culture, Community and Commerce

GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is safe and well-tolerated in healthy elderly volunteers, showing a favourable pharmacokinetic profile and high brain penetration. These findings support the advancement of SUL-238 into further clinical development for Alzheimer's and other neurodegenerative diseases.

Moderna Announces Data to be Presented at ESMO Congress 2025

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2025 European Society for Medical Oncology (ESMO) Congress, which will be held October 17-21, 2025 in Berlin, Germany. This includes a mini oral presentation on mRNA-4359, Moderna's investigational mRNA-based therapy designed to elicit T-cell immune responses against tumor and immunosuppressive cells, as well as two poster presentations on intismeran autogene (V940/mRNA-4157). Intismeran autogene is jointly developed by Moderna and Merck, known as MSD outside of the United States and Canada.

American Marconi Wireless News - Boulevard (English)